European Journal of Health Economics

Papers
(The H4-Index of European Journal of Health Economics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues118
COVID-19 and income inequality in OECD countries93
Are regions equal in adversity? A spatial analysis of spread and dynamics of COVID-19 in Europe55
The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes54
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies45
Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy43
Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life42
The economic burden of obesity in Italy: a cost-of-illness study41
Health effects from heat waves in France: an economic evaluation36
More room for telemedicine after COVID-19: lessons for primary care?35
COVID-19 and the role of inequality in French regional departments30
General population normative data for the EQ-5D-3L in the five largest European economies28
Efficiency and productivity of health systems in prevention and control of non-communicable diseases in China, 2008–201528
Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states26
The remarkably frequent use of EQ-5D in non-economic research25
Effect of financial inclusion on out-of-pocket health expenditure: empirics from Ghana23
Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan22
Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 201822
What is the best approach to adopt for identifying the domains for a new measure of health, social care and carer-related quality of life to measure quality-adjusted life years? Application to the dev21
Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies21
Health state utility values by cancer stage: a systematic literature review21
Does the universal medical insurance system reduce catastrophic health expenditure among middle-aged and elderly households in China? A longitudinal analysis21
Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A21
0.049803018569946